or

search:

Oxycodone (OxyContin, Percocet, Percodan)  


Oxycodone is a central nervous system depressant. Oxycodone's action appears to work through stimulating the opioid receptors found in the central nervous system that activate responses ranging from analgesia to respiratory depression to euphoria. People who take the drug repeatedly can develop a tolerance or resistance to the drug's effects. Thus, a cancer patient can take a dose of oxycodone on a regular basis that would be fatal in a person never exposed to oxycodone or another opioid. Most individuals who abuse oxycodone seek to gain the euphoric effects, mitigate pain, and avoid withdrawal symptoms associated with oxycodone or heroin abstinence.

Oxycodone has a high abuse potential and is prescribed for moderate to high pain relief associated with injuries, bursitis, dislocation, fractures, neuralgia, arthritis, and lower back and cancer pain. It is also used postoperatively and for pain relief after childbirth. OxyContin, Percocet, Percodan, and Tylox are trade name oxycodone products.

OxyContin is designed to be swallowed whole; however, abusers ingest the drug in a variety of ways. OxyContin abusers often chew the tablets or crush the tablets and snort the powder. Because oxycodone is water soluble, crushed tablets can be dissolved in water and the solution injected. The latter two methods lead to the rapid release and absorption of oxycodone.

Source: National Drug Intelligence Center (NDIC), "OxyContin Diversion and Abuse," January 2001

SIDE EFFECTS (when taken as directed):
Constipation, dryness of the mouth, confusion, sedation, light-headedness, respiratory depression, nausea, vomiting, headache, sweating

SYMPTOMS OF OVERDOSE:
Slow breathing, seizures, dizziness, weakness, loss of consciousness, coma, confusion, cold or clammy skin, small pupils

 

 


Narcotics

Prescription Drugs



 


Report on the Review of Sales Transactions for Oxycodone-based Products in Atlantic Canada
(Office of Controlled Substances, Health Canada, July 2005)

Nonmedical Oxycodone Users: A Comparison with Heroin Users
(The NSDUH Report, January 21, 2005)

OxyContin: Diversion, Availability & Abuse; NDIC Intelligence Bulletin
(August 2004)

Oxycodone, Hydrocodone and Polydrug Use, 2002 (The DAWN Report, July 2004)

Treatment Admissions Involving Narcotic Painkillers: 2002 Update (The DASIS Report, July 23, 2004)

OxyContin: Prescription Drug Abuse
(CSAT Advisory, April 2001)

Narcotics Analgesics:
The DAWN Report (January 2003)

 

 


Oxycodone Emergency Department mentions increased 70% from 2000 to 2001, compared to the 186% surge in mentions from 1999 to 2000. However, mentions of most (other) narcotic analgesics did not increase from 2000 to 2001.

Source: Substance Abuse and Mental Health Services Administration's (SAMHSA), Drug Abuse Warning Network (DAWN)